J&J | Себестоимость



Cost Of Sales Изменить Дата
AbbVie USD 4B 394M 2025-03
Abbott USD 4.44B 502M 2025-03
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Baxter International USD 1.74B 73M 2024-12
Bayer EUR 5.72B 633M 2024-12
Becton, Dickinson and Co. USD 3.02B 82M 2025-03
Biogen USD 629.3M 45.8M 2025-03
Boston Scientific USD 1.47B 5M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
CONMED USD 140.09M 7.51M 2025-03
Cooper Companies USD 304.5M 36.2M 2025-01
Dexcom USD 447M 42.8M 2025-03
Edwards Lifesciences USD 301.6M 9.4M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Globus Medical USD 263.44M 7.08M 2024-12
Hologic USD 444.6M 3.3M 2025-03
Indivior 44M 21M 2025-03
Insulet USD 166.6M 200K 2024-12
Integra LifeSciences USD 176.8M 14.01M 2024-12
Intuitive Surgical USD 795.7M 24.4M 2025-03
J&J USD 7.3B 189M 2025-03
Medtronic USD 2.78B 160M 2025-01
Merck USD 2.76B 944M 2025-03
Merit Medical Systems USD 733.32M 551.15M 2025-03
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Stryker USD 2.12B 118M 2025-03
Tandem Diabetes Care USD 116.02M 9.18M 2025-03
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zimmer Biomet Holdings USD 586.7M 48.1M 2024-12
Zoetis USD 707M 8M 2024-12



J&J Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.